Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
10.24
-0.36 (-3.40%)
At close: Oct 8, 2025, 4:00 PM EDT
10.24
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:00 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.66 billion as of October 8, 2025. Its market cap has decreased by -46.90% in one year.
Market Cap
2.66B
Enterprise Value
10.96B
1-Year Change
-46.90%
Ranking
Category
Stock Price
$10.24
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.66B, a decrease of -68.34%. That is a compound annual growth rate of -22.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.76B | -28.28% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |